To help support staff in global engagement endeavours, we have funds available from Erasmus and Santander under the revised Staff Mobility scheme.
Erasmus staff mobility funding can be used to support the travel, accommodation and subsistence costs of academic and professional support staff undertaking training at an organisation/ institution in Europe. It can also be used to support the same costs for any academic staff member wishing to teach at a European university. The guidance to the application form contains more details as to the amounts available and duration and our priority institutions. Erasmus funds are a great way to build networks and gain a great experience.
Santander staff mobility funding can be used to support travel, accommodation and subsistence costs for staff wishing to develop research, education and professional practice projects. This fund is ideal to support academic staff in travelling to an international university in order to develop a collaborative relationship.
All the details needed to make the application as well as sources of advice can be found on this dedicated webpage.
The deadline for submissions is 9am on 24th October 2016.











BU students’ publishing success
BU presentation at the University of Bristol
Art and Design: History, Practice and Theory academics – would you like to get more involved in preparing our next REF submission?
UKCGE Recognised Research Supervision Programme: Final Deadline Reminder
The significance of Rights and Protocols in Disaster Response
Celebrate World Wellbeing Week This June
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease